Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very ...
Novo Nordisk (NYSE:NVO) climbs about 2% on Monday afternoon after it says it will not raise its offer for Metsera ...
The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...
The Hearty Soul on MSN
Study Suggests Possible Link Between Pfizer COVID-19 Vaccine and Vision-Related Eye Conditions
Using Your Credit Card at the Checkout Is Set to Get a Lot More Complicated At Kris Jenner's birthday bash in Beverly Hills, ...
Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market s | Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease ...
The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...
That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
Pfizer not only beat expectations last quarter, but also boosted its guidance.
Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...
By now, you know that the COVID-19 vaccine is the best way to protect against severe COVID infections and reduce your chances ...
Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback